Point Nine Capital

Point Nine is a Berlin-based early-stage venture capital firm focused primarily on software investments rather than therapeutics or healthcare operations. The firm backs seed and related early-stage startups globally, with a particular emphasis on B2B SaaS, AI-enabled software, and digital marketplaces. It typically invests roughly $1 million to $10 million per company and provides hands-on support to founders through its partner network and community resources. Although some portfolio companies operate in healthcare technology, Point Nine itself is not a biotech, pharma, or healthcare company and does not appear to develop drugs, diagnostics, or clinical-stage products.